INTERLEUKIN-12 INDUCES THE DIFFERENTIATION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I-PRIMED CYTOTOXIC T-LYMPHOCYTE PRECURSORS INTO ALLOSPECIFIC CYTOTOXIC EFFECTORS

被引:95
作者
CHOUAIB, S
CHEHIMI, J
BANI, L
GENETET, N
TURSZ, T
GAY, F
TRINCHIERI, G
MAMICHOUAIB, F
机构
[1] CHILDRENS HOSP,PHILADELPHIA,PA 19104
[2] UNIV RENNES 1,RECH IMMUNOL GRP,F-35016 RENNES,FRANCE
[3] INST GUSTAVE ROUSSY,URA 1156,F-94805 VILLEJUIF,FRANCE
[4] WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104
[5] INST GUSTAVE ROUSSY,INSERM,U333,F-94805 VILLEJUIF,FRANCE
关键词
CYTOKINES; ALLOGENEIC RESPONSE;
D O I
10.1073/pnas.91.26.12659
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The production of interleukin 12 (IL-12) following allogeneic stimulation and its involvement in the differentiation of allospecific cytotoxic T lymphocytes (CTLs) have been investigated. Supernatants of mixed lymphocyte cultures had detectable levels of IL-12 p40 which were completely abrogated after depletion of responder cells from monocytes. While addition to the culture of anti-IL-12 neutralizing antibodies partially inhibited the allogeneic proliferative response and the subsequent CTL activity, addition of IL-12 stimulated both responses, suggesting that endogenously produced IL-12 plays a role in the development of alloreactivity. Furthermore, using primary mixed cultures of lymphocytes from major histocompatibility complex-recombinant siblings identical for class II antigens and displaying class I disparity, we demonstrated that addition of recombinant IL-12 at the sensitizing phase of the primary mixed lymphocyte culture induced CTL activity. Under these stimulation conditions, addition of recombinant IL-12 also triggered cell proliferation, indicating that IL-12 provides both growth and differentiation signals. The mechanism underlying this process does not appear to require IL-2, since IL-12-mediated CTL generation was not abrogated by anti-IL-2 alpha-chain antibodies. IL-12 increased granzyme B and perforin mRNA accumulation in major histocompatibility complex class I-primed lymphocytes, suggesting that this cytokine activates these two genes in CTL precursors. We conclude that IL-12 can stimulate the generation of alloreactive CTLs. We suggest that IL-12 may play a role in helper cell-independent CTL generation.
引用
收藏
页码:12659 / 12663
页数:5
相关论文
共 36 条
[1]   COOPERATION OF NATURAL-KILLER-CELL STIMULATORY FACTOR INTERLEUKIN-12 WITH OTHER STIMULI IN THE INDUCTION OF CYTOKINES AND CYTOTOXIC CELL-ASSOCIATED MOLECULES IN HUMAN T-CELLS AND NK-CELLS [J].
ASTEAMEZAGA, M ;
DANDREA, A ;
KUBIN, M ;
TRINCHIERI, G .
CELLULAR IMMUNOLOGY, 1994, 156 (02) :480-492
[2]  
BLOOM ET, 1994, J IMMUNOL, V152, P4242
[3]   ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF INTERLEUKIN-12 AGAINST MURINE TUMORS [J].
BRUNDA, MJ ;
LUISTRO, L ;
WARRIER, RR ;
WRIGHT, RB ;
HUBBARD, BR ;
MURPHY, M ;
WOLF, SF ;
GATELY, MK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04) :1223-1230
[4]   RAPID DNA TYPING OF CLASS-II HLA ANTIGENS USING THE POLYMERASE CHAIN-REACTION AND REVERSE DOT BLOT HYBRIDIZATION [J].
BUYSE, I ;
DECORTE, R ;
BAENS, M ;
CUPPENS, H ;
SEMANA, G ;
EMONDS, MP ;
MARYNEN, P ;
CASSIMAN, JJ .
TISSUE ANTIGENS, 1993, 41 (01) :1-14
[5]   INDUCTION OF INTERFERON-GAMMA PRODUCTION BY NATURAL-KILLER-CELL STIMULATORY FACTOR - CHARACTERIZATION OF THE RESPONDER CELLS AND SYNERGY WITH OTHER INDUCERS [J].
CHAN, SH ;
PERUSSIA, B ;
GUPTA, JW ;
KOBAYASHI, M ;
POSPISIL, M ;
YOUNG, HW ;
WOLF, SF ;
YOUNG, D ;
CLARK, SC ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :869-879
[6]   ENHANCING EFFECT OF NATURAL-KILLER-CELL STIMULATORY FACTOR (NKSF/INTERLEUKIN-12) ON CELL-MEDIATED CYTOTOXICITY AGAINST TUMOR-DERIVED AND VIRUS-INFECTED CELLS [J].
CHEHIMI, J ;
VALIANTE, NM ;
DANDREA, A ;
RENGARAJU, M ;
ROSADO, Z ;
KOBAYASHI, M ;
PERUSSIA, B ;
WOLF, SF ;
STARR, SE ;
TRINCHIERI, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (08) :1826-1830
[7]   NATURAL-KILLER (NK) CELL STIMULATORY FACTOR INCREASES THE CYTOTOXIC ACTIVITY OF NK CELLS FROM BOTH HEALTHY DONORS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED PATIENTS [J].
CHEHIMI, J ;
STARR, SE ;
FRANK, I ;
RENGARAJU, M ;
JACKSON, SJ ;
LLANES, C ;
KOBAYASHI, M ;
PERUSSIA, B ;
YOUNG, D ;
NICKBARG, E ;
WOLF, SF ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) :789-796
[8]   IMPAIRED INTERLEUKIN-12 PRODUCTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS [J].
CHEHIMI, J ;
STARR, SE ;
FRANK, I ;
DANDREA, A ;
MA, XJ ;
MACGREGOR, RR ;
SENNELIER, J ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1361-1366
[9]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[10]  
CHOUAIB S, 1988, J IMMUNOL, V141, P423